PM537. GPR52 agonists show pro-cognitive properties

por von Heimendahl, Moritz, Arban, Roberto, Deiana, Serena, Hobson, Scott, Rosenbrock, Holger, Schülert, Niklas
Publicado 2016

Targeting the dopamine D(1) receptor or its downstream signalling by inhibiting phosphodiesterase‐1 improves cognitive performance

por Pekcec, Anton, Schülert, Niklas, Stierstorfer, Birgit, Deiana, Serena, Dorner‐Ciossek, Cornelia, Rosenbrock, Holger
Publicado 2018

M181. DEVELOPMENTAL PROGRESSION OF INTERNEURON NETWORK DEFICITS IN A 15Q13.3 MICRODELETION MOUSE MODEL – A GLIMPSE ON ADOLESCENT PRIMING FOR SCHIZOPHRENIA?

por Funk, Marzieh, Jaeger, Stefan, Schülert, Niklas, Dorner-Ciossek, Cornelia, Rosenbrock, Holger, Mack, Volker
Publicado 2020

PT745. Targeting the dopamine 1 receptor or its downstream signalling by inhibiting phosphodiesterase-1 improves cognitive performance

por Pekcec, Anton, Schülert, Niklas, Giovannini, Riccardo, Pfau, Roland, Stierstorfer, Birgit, Hobson, Scott, Rosenbrock, Holger
Publicado 2016

S141. TRANSGENIC OVEREXPRESSION OF THE TYPE III ISOFORM OF NEUREGULIN 1 IN MICE INDUCES ABNORMALITIES ON AUDITORY EVENT RELATED EEG BIOMARKERS RELATED TO SCHIZOPHRENIA

por Rosenbrock, Holger, Nissen, Wiebke, Arban, Roberto, Moritz, Rossner, Markus, Schwab, Dorner-Ciossek, Cornelia, Schülert, Niklas
Publicado 2018